XERS icon

Xeris Biopharma Holdings
XERS

Overview Fund Activity

92 hedge funds and large institutions have $80.4M invested in Xeris Biopharma Holdings in 2023 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 27 increasing their positions, 24 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
92
Holders Change
-5
Holders Change %
-5.15%
% of All Funds
1.47%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
9
Increased
27
Reduced
24
Closed
14
Calls
$659K
Puts
$61K
Net Calls
+$598K
Net Calls Change
-$1.22M

Top Buyers

1
JPMorgan Chase & Co
1
JPMorgan Chase & Co
New York
$1.25M
2
RCMNY
2
Rubric Capital Management (New York)
New York
$695K
3
GCP
3
GSA Capital Partners
United Kingdom
$515K
4
DAM
4
Deltec Asset Management
New York
$1.01M
5
Vanguard Group
5
Vanguard Group
Pennsylvania
$11.2M

Top Sellers

1
NMC
1
NEA Management Company
Maryland
$0
2
SCM
2
Stonepine Capital Management
Oregon
$14.1M
3
Millennium Management
3
Millennium Management
New York
$0
4
BlackRock
4
BlackRock
New York
$13.7M
5
BCM
5
Bridgeway Capital Management
Texas
$431K
Name Holding Trade Value Shares
Change 		Shares
Change %
CSS
101
Cubist Systematic Strategies
Connecticut
– -$10.6K -7,968 Closed
PMEF
102
Point72 Middle East FZE
United Arab Emirates
– -$8.9K -6,689 Closed
KIA
103
Kraematon Investment Advisors
Massachusetts
– -$3.84K -2,885 Closed
CS
104
Credit Suisse
Switzerland
– -$7 -5 Closed
1 2 3 4
5